Sylvie Gazzéri

4.4k total citations
63 papers, 3.5k citations indexed

About

Sylvie Gazzéri is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sylvie Gazzéri has authored 63 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 39 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Sylvie Gazzéri's work include Cancer-related Molecular Pathways (25 papers), RNA modifications and cancer (19 papers) and Epigenetics and DNA Methylation (9 papers). Sylvie Gazzéri is often cited by papers focused on Cancer-related Molecular Pathways (25 papers), RNA modifications and cancer (19 papers) and Epigenetics and DNA Methylation (9 papers). Sylvie Gazzéri collaborates with scholars based in France, United States and Spain. Sylvie Gazzéri's co-authors include Élisabeth Brambilla, Béatrice Eymin, Christian Brambilla, Sylvie Lantuéjoul, D Moro, Jean‐Luc Coll, Valérie Gouyer, Saadi Khochbin, A Negoescu and Arnaud Van Den Broeck and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Sylvie Gazzéri

63 papers receiving 3.4k citations

Peers

Sylvie Gazzéri

ONCOL

PRM

EPIDE

Marion Dorsch United States

Heng‐Huan Lee United States

Gareth L. Bond United Kingdom

Robert J.C. Slebos Netherlands

Seung Myung Dong South Korea

Masayuki Miyake Japan

Tsutomu Kawaguchi Japan

Audrey Petitjean France

Sun W. Tam United States

Joseph N. Contessa United States

Marion Dorsch United States

Sylvie Gazzéri

2.2k ×0.9

1.2k ×0.8

ONCOL

591 ×0.9

345 ×0.6

PRM

170 ×0.5

EPIDE

Citations per year, relative to Sylvie Gazzéri Sylvie Gazzéri (= 1×) peers Marion Dorsch

Countries citing papers authored by Sylvie Gazzéri

Since Specialization

Citations

This map shows the geographic impact of Sylvie Gazzéri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Gazzéri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Gazzéri more than expected).

Fields of papers citing papers by Sylvie Gazzéri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Gazzéri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Gazzéri. The network helps show where Sylvie Gazzéri may publish in the future.

Co-authorship network of co-authors of Sylvie Gazzéri

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Gazzéri. A scholar is included among the top collaborators of Sylvie Gazzéri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Gazzéri. Sylvie Gazzéri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fayçal, Chérine Abou, Sylvie Gazzéri, & Béatrice Eymin. (2019). A VEGF-A/SOX2/SRSF2 network controls VEGFR1 pre-mRNA alternative splicing in lung carcinoma cells. Scientific Reports. 9(1). 336–336. 30 indexed citations

Fraipont, Florence de, Sylvie Gazzéri, William C. Cho, & Béatrice Eymin. (2019). Circular RNAs and RNA Splice Variants as Biomarkers for Prognosis and Therapeutic Response in the Liquid Biopsies of Lung Cancer Patients. Frontiers in Genetics. 10. 390–390. 79 indexed citations

Gazzéri, Sylvie. (2018). L’EGFR nucléaire : un nouveau mode de signalisation dans les cancers. Biologie Aujourd hui. 212(1-2). 27–33. 10 indexed citations

Fayçal, Chérine Abou, Élisabeth Brambilla, Jackeline Agorreta, et al.. (2018). The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma. British Journal of Cancer. 118(12). 1596–1608. 15 indexed citations

Fayçal, Chérine Abou, Sylvie Gazzéri, & Béatrice Eymin. (2015). RNA splicing, cell signaling, and response to therapies. Current Opinion in Oncology. 28(1). 58–64. 16 indexed citations

Gout, Stéphanie, et al.. (2012). Abnormal Expression of the Pre-mRNA Splicing Regulators SRSF1, SRSF2, SRPK1 and SRPK2 in Non Small Cell Lung Carcinoma. PLoS ONE. 7(10). e46539–e46539. 124 indexed citations

Eymin, Béatrice, et al.. (2010). The ARF tumor suppressor: Structure, functions and status in cancer. International Journal of Cancer. 127(10). 2239–2247. 134 indexed citations

Eymin, Béatrice & Sylvie Gazzéri. (2010). Role of cell cycle regulators in lung carcinogenesis. Cell Adhesion & Migration. 4(1). 114–123. 79 indexed citations

Eymery, Angéline, Béatrice Horard, Geneviève Fourel, et al.. (2009). A transcriptomic analysis of human centromeric and pericentric sequences in normal and tumor cells. Nucleic Acids Research. 37(19). 6340–6354. 94 indexed citations

10.

Broeck, Arnaud Van Den, Élisabeth Brambilla, Denis Moro‐Sibilot, et al.. (2008). Loss of Histone H4K20 Trimethylation Occurs in Preneoplasia and Influences Prognosis of Non–Small Cell Lung Cancer. Clinical Cancer Research. 14(22). 7237–7245. 156 indexed citations

11.

Salon, Caroline, Élisabeth Brambilla, Christian Brambilla, et al.. (2007). Altered pattern of Cul‐1 protein expression and neddylation in human lung tumours: relationships with CAND1 and cyclin E protein levels. The Journal of Pathology. 213(3). 303–310. 62 indexed citations

12.

Col, Edwige, Cécile Caron, Christine Chable-Bessia, et al.. (2005). HIV‐1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic stresses. The EMBO Journal. 24(14). 2634–2645. 78 indexed citations

13.

Eymin, Béatrice, et al.. (2003). p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice. Oncogene. 22(12). 1822–1835. 93 indexed citations

14.

Eymin, Béatrice, Sylvie Gazzéri, Christian Brambilla, & Élisabeth Brambilla. (2001). Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma. Oncogene. 20(14). 1678–1687. 96 indexed citations

15.

Eymin, Béatrice, Lucie Karayan, Paule Seité, et al.. (2001). Human ARF binds E2F1 and inhibits its transcriptional activity. Oncogene. 20(9). 1033–1041. 138 indexed citations

16.

Brambilla, Élisabeth, Denis Moro, Sylvie Gazzéri, & Christian Brambilla. (1999). Alterations of expression of Rb, p16INK4A and cyclin D1 in non-small cell lung carcinoma and their clinical significance. The Journal of Pathology. 188(4). 351–360. 95 indexed citations

17.

Gazzéri, Sylvie, et al.. (1998). Mechanisms of p16INK4A inactivation in non small-cell lung cancers. Oncogene. 16(4). 497–504. 146 indexed citations

18.

Gazzéri, Sylvie, Élisabeth Brambilla, Claude Caron de Fromentel, et al.. (1994). p53 genetic abnormalities and myc activation in human lung carcinoma. International Journal of Cancer. 58(1). 24–32. 59 indexed citations

19.

Brambilla, E, Sylvie Gazzéri, Valérie Gouyer, & C Brambilla. (1993). [Mechanisms of bronchial oncogenesis].. PubMed. 13(6). 372–80. 1 indexed citations

20.

Brambilla, Élisabeth, D Moro, Sylvie Gazzéri, et al.. (1991). Cytotoxic chemotherapy induces cell differentiation in small-cell lung carcinoma.. Journal of Clinical Oncology. 9(1). 50–61. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact